Literature DB >> 17404270

Human peripheral blood T regulatory cells (Tregs), functionally primed CCR4+ Tregs and unprimed CCR4- Tregs, regulate effector T cells using FasL.

Dolgor Baatar1, Purevdorj Olkhanud, Kenya Sumitomo, Dennis Taub, Ronald Gress, Arya Biragyn.   

Abstract

Regulatory CD25(+)CD4(+) T cells (Tregs) play an important role in the control of peripheral tolerance. In this study we demonstrate that human peripheral blood Tregs can be divided into two distinct populations based on the expression of CCR4. The majority ( approximately 75%) of freshly isolated Tregs express CCR4 and presumably represent memory-type Tregs. Interestingly, CCR4(-) Tregs require anti-CD3 Ab-mediated activation to acquire a regulatory activity, while CCR4(+) Tregs appear to be already primed to suppress the proliferation of CD8(+) T cells. CCR4 is also expressed on CD25(low)CD4(+) T cells (CCR4(+) non-Tregs) that mostly suppress Th1-type polarization without affecting T cell proliferation, presumably via the production of immunomodulatory cytokines like IL-10. In contrast, CCR4(+) Tregs express FasL to primarily regulate T cell proliferation via a contact-mediated process involving FasL/Fas signaling, a major regulatory pathway of T cell homeostasis. Finally, we also demonstrate that the depletion of CCR4(+) T cells leads to Th1-type polarization of CD4(+) T cells and augmentation of CD8(+) T cell responses to tumor Ags.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17404270      PMCID: PMC2262930          DOI: 10.4049/jimmunol.178.8.4891

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

1.  CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells.

Authors:  Yong Zheng; Claire N Manzotti; Michael Liu; Fiona Burke; Karen I Mead; David M Sansom
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

2.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.

Authors:  S Sakaguchi; N Sakaguchi; M Asano; M Itoh; M Toda
Journal:  J Immunol       Date:  1995-08-01       Impact factor: 5.422

3.  Human T regulatory cells can use the perforin pathway to cause autologous target cell death.

Authors:  William J Grossman; James W Verbsky; Winfried Barchet; Marco Colonna; John P Atkinson; Timothy J Ley
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

4.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Authors:  Tyler J Curiel; George Coukos; Linhua Zou; Xavier Alvarez; Pui Cheng; Peter Mottram; Melina Evdemon-Hogan; Jose R Conejo-Garcia; Lin Zhang; Matthew Burow; Yun Zhu; Shuang Wei; Ilona Kryczek; Ben Daniel; Alan Gordon; Leann Myers; Andrew Lackner; Mary L Disis; Keith L Knutson; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2004-08-22       Impact factor: 53.440

5.  Riboprobe expression cassettes for measuring IGF-I, beta-actin and glyceraldehyde 3-phosphate dehydrogenase transcripts.

Authors:  A Biragyn; S Arkins; K W Kelley
Journal:  J Immunol Methods       Date:  1994-02-10       Impact factor: 2.303

6.  Minimum length of an idiotypic peptide and a model for its binding to a major histocompatibility complex class II molecule.

Authors:  B Bogen; J D Lambris
Journal:  EMBO J       Date:  1989-07       Impact factor: 11.598

7.  A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis.

Authors:  H Groux; A O'Garra; M Bigler; M Rouleau; S Antonenko; J E de Vries; M G Roncarolo
Journal:  Nature       Date:  1997-10-16       Impact factor: 49.962

8.  In vitro and in vivo cytotoxic activities of recombinant immunotoxin 8H9(Fv)-PE38 against breast cancer, osteosarcoma, and neuroblastoma.

Authors:  Masanori Onda; Qing-cheng Wang; Hong-fen Guo; Nai-Kong V Cheung; Ira Pastan
Journal:  Cancer Res       Date:  2004-02-15       Impact factor: 13.312

9.  The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1.

Authors:  E L Berg; T Yoshino; L S Rott; M K Robinson; R A Warnock; T K Kishimoto; L J Picker; E C Butcher
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

10.  Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis.

Authors:  Vissia Viglietta; Clare Baecher-Allan; Howard L Weiner; David A Hafler
Journal:  J Exp Med       Date:  2004-04-05       Impact factor: 14.307

View more
  41 in total

1.  Pancreatic islets engineered with SA-FasL protein establish robust localized tolerance by inducing regulatory T cells in mice.

Authors:  Esma S Yolcu; Hong Zhao; Laura Bandura-Morgan; Chantale Lacelle; Kyle B Woodward; Nadir Askenasy; Haval Shirwan
Journal:  J Immunol       Date:  2011-11-07       Impact factor: 5.422

2.  Thymic stromal lymphopoietin is a key mediator of breast cancer progression.

Authors:  Purevdorj B Olkhanud; Yrina Rochman; Monica Bodogai; Enkhzol Malchinkhuu; Katarzyna Wejksza; Mai Xu; Ronald E Gress; Charles Hesdorffer; Warren J Leonard; Arya Biragyn
Journal:  J Immunol       Date:  2011-04-13       Impact factor: 5.422

Review 3.  Regulatory T cells in AKI.

Authors:  Gilbert R Kinsey; Rahul Sharma; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2013-10-17       Impact factor: 10.121

4.  Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells.

Authors:  Purevdorj B Olkhanud; Dolgor Baatar; Monica Bodogai; Fran Hakim; Ronald Gress; Robin L Anderson; Jie Deng; Mai Xu; Susanne Briest; Arya Biragyn
Journal:  Cancer Res       Date:  2009-06-30       Impact factor: 12.701

5.  Transplantation survival is maintained by granzyme B+ regulatory cells and adaptive regulatory T cells.

Authors:  David C Gondek; Victor Devries; Elizabeth C Nowak; Li-Fan Lu; Kathryn A Bennett; Zachary A Scott; Randolph J Noelle
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

6.  Expansion of allospecific regulatory T cells after anergized, mismatched bone marrow transplantation.

Authors:  Jeffrey K Davies; Lee M Nadler; Eva C Guinan
Journal:  Sci Transl Med       Date:  2009-10-07       Impact factor: 17.956

7.  Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cells.

Authors:  Purevdorj B Olkhanud; Bazarragchaa Damdinsuren; Monica Bodogai; Ronald E Gress; Ranjan Sen; Katarzyna Wejksza; Enkhzol Malchinkhuu; Robert P Wersto; Arya Biragyn
Journal:  Cancer Res       Date:  2011-03-28       Impact factor: 12.701

Review 8.  T-helper and T-regulatory cells modulation in head and neck squamous cell carcinoma.

Authors:  Daniele Maggioni; Lorenzo Pignataro; Werner Garavello
Journal:  Oncoimmunology       Date:  2017-05-04       Impact factor: 8.110

9.  Treatment with anti-FasL antibody preserves memory lymphocytes and virus-specific cellular immunity in macaques challenged with simian immunodeficiency virus.

Authors:  Bhawna Poonia; Maria S Salvato; Hideo Yagita; Toshihiro Maeda; Ko Okumura; C David Pauza
Journal:  Blood       Date:  2009-06-04       Impact factor: 22.113

10.  Targeted reduction of CCR4⁺ cells is sufficient to suppress allergic airway inflammation.

Authors:  Akifumi Honjo; Hirohisa Ogawa; Masahiko Azuma; Toshifumi Tezuka; Saburo Sone; Arya Biragyn; Yasuhiko Nishioka
Journal:  Respir Investig       Date:  2013-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.